Inventor · disambiguated record
Kenneth Mark Parnell
Also filed as: PARNELL KENNETH MARK
11 granted patents·3 pending applications·51 citations·filing 2013–2024
89Inventor score
Top patents by PatentIndex Score
14 records- 0195US11155522B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2020·Granted Oct 26, 2021·4 cites·41 claims
- 0295US9394257B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2013·Granted Jul 19, 2016·22 cites·52 claims
- 0393US12187682B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2023·Granted Jan 7, 2025·1 cites·9 claims
- 0493US11724989B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2021·Granted Aug 15, 2023·2 cites·23 claims
- 0593US10214492B2Heterocyclic inhibitors of MCT4VETTORE LLC·Filed 2017·Granted Feb 26, 2019·6 cites·5 claims
- 0692US11292767B2Heterocyclic inhibitors of MCT4VETTORE LLC·Filed 2018·Granted Apr 5, 2022·5 cites·31 claims
- 0792US10202350B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2016·Granted Feb 12, 2019·6 cites·39 claims
- 0887US2025257039A1Mct4 inhibitors for treating diseaseVETTORE LLC·Filed 2024·Application pending·0 cites
- 0982US10766865B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·1 cites·17 claims
- 1082US10472328B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2018·Granted Nov 12, 2019·2 cites·20 claims
- 1179US10207996B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2016·Granted Feb 19, 2019·2 cites·37 claims
- 1277US12492171B2Heterocyclic inhibitors of MCT4VETTORE LLC·Filed 2022·Granted Dec 9, 2025·0 cites·9 claims
- 1372US2019112274A1Mct4 inhibitors for treating diseaseVETTORE LLC·Filed 2018·Application pending·0 cites
- 1471US2021002233A1Pkm2 modulators and methods for their useSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth Mark Parnell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →